We have previously demonstrated that siRNA targeting of ADAM15 in prostate cancer cells not only reduced tumor cell migration and invasion, it also altered the tumor cell adhesion profile and completely inhibited the overt metastasis of these cells in vivo [22,23]. This evidence concerns the gene ADAM15 and prostate carcinoma.